The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Rituximab, an Anti-CD20 Monoclonal Antibody: History and Mechanism of Action
Open accessAbstract
Rituximab, chimeric anti-human CD20, is approved for treatment of B-cell lymphoma in adults. It is being used experimentally in other various immune-related diseases such as immune thrombocytopenic purpura, systemic lupus erythematosus, myasthenia gravis and rheumatoid arthritis. In transplant recipients, it is used for treatment of post-transplant lymphoproliferative disease, to anecdotally reduce pre-formed anti-HLA and anti-ABO antibodies and for the prevention and treatment of acute rejection. This article primarily reviews the science behind rituximab: its history, pharmacokinetics and potential mechanism of action. A need for controlled clinical trials is clearly indicated before the widespread use of this drug in transplant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McLaughlin, P., Grillo-López, A. J., Link, B. K., Levy, R., Czuczman, M. S., Williams, M. E., Heyman, M. R., Bence-Bruckler, I., White, C. A., Cabanillas, F., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2825 · Cited by 2,755
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
Reff, M., Carner, K., Chambers, K., Chinn, P., Leonard, J., Raab, R., Newman, R., Hanna, N., & Anderson, D. (1994) · Blood · doi:10.1182/blood.v83.2.435.435 · Cited by 1,999
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells
Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304
Weng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300
Humoral Immunity Due to Long-Lived Plasma Cells
Slifka, M. K., Antia, R., Whitmire, J. K., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80541-5 · Cited by 1,245
Maloney, D., Liles, T., Czerwinski, D., Waldichuk, C., Rosenberg, J., Grillo-Lopez, A., & Levy, R. (1994) · Blood · doi:10.1182/blood.v84.8.2457.2457 · Cited by 762
Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray Profiling
Sarwal, M., Chua, M.-S., Kambham, N., Hsieh, S.-C., Satterwhite, T., Masek, M., & Salvatierra, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035588 · Cited by 701
Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy
Gong, Q., Ou, Q., Ye, S., Lee, W. P., Cornelius, J., Diehl, L., Lin, W. Y., Hu, Z., Lu, Y., Chen, Y., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.817 · Cited by 543
Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes
Edwards, J. C. W., & Cambridge, G. (2001) · Rheumatology · doi:10.1093/rheumatology/40.2.205 · Cited by 523
Pillai, S., Cariappa, A., & Moran, S. T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115728 · Cited by 466
Anolik, J. H., Campbell, D., Felgar, R. E., Young, F., Sanz, I., Rosenblatt, J., & Looney, R. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10764 · Cited by 429
A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
Nadler, L. M., Ritz, J., Hardy, R., Pesando, J. M., Schlossman, S. F., & Stashenko, P. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110005 · Cited by 399
The role of APRIL and BAFF in lymphocyte activation
Schneider, P. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.04.005 · Cited by 360
Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion
Leandro, M. J., Edwards, J. C. W., & Cambridge, G. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.10.883 · Cited by 345
Long-lived plasma cells: a mechanism for maintaining persistent antibody production
Slifka, M. K., & Ahmed, R. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80162-3 · Cited by 321
Rituximab as Treatment for Refractory Kidney Transplant Rejection
Becker, Y. T., Becker, B. N., Pirsch, J. D., & Sollinger, H. W. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00454.x · Cited by 309
Rituximab treatment results in impaired secondary humoral immune responsiveness
van der Kolk, L. E., Baars, J. W., Prins, M. H., & van Oers, M. H. J. (2002) · Blood · doi:10.1182/blood.v100.6.2257 · Cited by 284
Einfeld, D. A., Brown, J. P., Valentine, M. A., Clark, E. A., & Ledbetter, J. A. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02867.x · Cited by 278
Vieira, C. A., Agarwal, A., Book, B. K., Sidner, R. A., Bearden, C. M., Gebel, H. M., Roggero, A. L., Fineberg, N. S., Taber, T., Kraus, M. A., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000112934.12622.2b · Cited by 271
Self-citationRivera, A., Chen, C.-C., Ron, N., Dougherty, J. P., & Ron, Y. (2001) · International Immunology · doi:10.1093/intimm/13.12.1583 · Cited by 204
Ng, C. M., Bruno, R., Combs, D., & Davies, B. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005277075 · Cited by 203
Lapointe, R., Bellemare‐Pelletier, A., Housseau, F., Thibodeau, J., & Hwu, P. (2003) · PubMed · Cited by 189
Ghielmini, M., Rufibach, K., Salles, G., Leoncini-Franscini, L., Léger-Falandry, C., Cogliatti, S., Fey, M., Martinelli, G., Stahel, R., Lohri, A., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi320 · Cited by 166
Hippen, B. E., DEMATTOS, A. M., Cook, W. J., Kew, C. E., & Gastona, R. S. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01009.x · Cited by 155
Tobinai, K., Kobayashi, Y., Narabayashi, M., Ogura, M., Kagami, Y., MORISHIMA, Y., Ohtsu, T., Igarashi, T., Sasaki, Y., Kinoshita, T., et al. (1998) · Annals of Oncology · doi:10.1023/a:1008265313133 · Cited by 151
Reactivation of hepatitis B virus with rituximab
Tsutsumi, Y., Kanamori, H., Mori, A., Tanaka, J., Asaka, M., Imamura, M., & Masauzi, N. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.3.599 · Cited by 135
Humoral Theory of Transplantation: Mechanism, Prevention, and Treatment
Cai, J., & Terasaki, P. I. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.01.021 · Cited by 109
B lymphocyte depletion therapy with rituximab in rheumatoid arthritis
Edwards, J., Leandro, M. J., & Cambridge, G. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.01.006 · Cited by 101
Bearden, C. M., Agarwal, A., Book, B. K., Vieira, C. A., Sidner, R. A., Ochs, H. D., Young, M., & Pescovitz, M. D. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2003.00646.x · Cited by 93
Self-citationCaspase Inhibition Improves Ischemia-Reperfusion Injury After Lung Transplantation
Quadri, S. M. S., Segall, L., de Perrot, M. E., Han, B., Edwards, V., Jones, N. L., Waddell, T. K., Liu, M., & Keshavjee, S. H. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00701.x · Cited by 92
Qian, J. H., Hashimoto, T., Fujiwara, H., & Hamaoka, T. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.3656 · Cited by 84
Sidner, R. A., Book, B. K., Agarwal, A., Bearden, C. M., Vieira, C. A., & Pescovitz, M. D. (2004) · Human Antibodies · doi:10.3233/hab-2004-13301 · Cited by 84
Self-citationDepletion of B Cells by a Humanized Anti-CD20 Antibody PRO70769 in Macaca Fascicularis
Vugmeyster, Y., Beyer, J. C., Howell, K., Combs, D., Fielder, P. J., Yang, J., Qureshi, F., Sandlund, B., Kawaguchi, L., Dummer, W., et al. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000155050.03916.04 · Cited by 79
Alausa, M., Almagro, U., Siddiqi, N., Zuiderweg, R., Medipalli, R., & Hariharan, S. (2004) · Clinical Transplantation · doi:10.1111/j.1399-0012.2004.00292.x · Cited by 76
Gonzalez‐Stawinski, G. V., Yu, P. B., Love, S. D., Parker, W., & Davis, R. D. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4980 · Cited by 72
Rituximab, Anti-CD20, Induces In Vivo Cytokine Release But Does Not Impair Ex Vivo T-Cell Responses
Agarwal, A., Vieira, C. A., Book, B. K., Sidner, R. A., Fineberg, N. S., & Pescovitz, M. D. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00502.x · Cited by 60
Self-citationB cell superantigens: a microbe?s answer to innate-like B cells and natural antibodies
Goodyear, C. S., & Silverman, G. J. (2005) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0190-2 · Cited by 48
The use of rituximab, anti‐CD20 monoclonal antibody, in pediatric transplantation
Pescovitz, M. D. (2004) · Pediatric Transplantation · doi:10.1046/j.1397-3142.2003.00135.x · Cited by 41
Self-citationMiana, A. N., Farney, A. C., & Farney, A. C. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00634.x · Cited by 37
Peter, H. H., & Warnatz, K. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.s61 · Cited by 19
Rituximab and other emerging monoclonal antibody therapies for lymphoma
Tobinai, K. (2002) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.7.2.289 · Cited by 13
Cited by
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function
Pescovitz, M. D., Greenbaum, C. J., Krause-Steinrauf, H., Becker, D. J., Gitelman, S. E., Goland, R., Gottlieb, P. A., Marks, J. B., McGee, P. F., Moran, A. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904452 · Cited by 1,093
Self-citationUpdate on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Lin, Y.-J., Anzaghe, M., & Schülke, S. (2020) · Cells · doi:10.3390/cells9040880 · Cited by 932
Myasthenia gravis: past, present, and future
Conti-Fine, B. M., Milani, M., & Kaminski, H. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29894 · Cited by 691
Rejection of the Kidney Allograft
Nankivell, B. J., & Alexander, S. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0902927 · Cited by 605
Mechanisms of killing by anti-CD20 monoclonal antibodies
Glennie, M. J., French, R. R., Cragg, M. S., & Taylor, R. P. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.151 · Cited by 515
Metadata
- Authors
- Pescovitz, M. D.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 6
- Issue
- 5
- Pages
- 859-866
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W2163100333
- Cited by
- 625
- References
- 41
- FWCI
- 25.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.